On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Shanghai Bocimed Pharmaceutical Co.,Ltd.

12 YRS

Shanghai, China

CNY 39.8 Million

19980 m²

100-500 people

Main Products: Relugolix / Carfilzomib / Ixazomib Citrate / Apalutamide / Avatrombopag / Fulvestrant / Lenvatinib Mesylate / Ruxolitinib Phosphate / Roxadustat / Brivaracetam

Shanghai, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

Brivaracetam / CAS 357336-20-0

OVERVIEW

Packaging

25 KG/Fibre Drum

Lead Time

14-30 days

REQUEST A QUOTATION

Submit

Get Free Samples

Less than 1KG required

DESCRIPTION

Brivaracetam

CAS:357336-20-0

Molecular formula: C11H20N2O2

Molecular weight: 212.28900

Appearance: white crystalline powder

Introduction: Brivaracetam was approved by the U.S. Food and Drug Administration (FDA) on February 19 for the adjuvant treatment of partial-onset seizures in patients 16 years of age and older. Compared with the previous generation drug levetiracetam, brivaracetam has a similar chemical structure and mechanism of action, and is the first antiepileptic drug approved by the FDA for the treatment of partial seizures since 2013.

Structural formula:

Typical Properties

Buvacetam is a new generation of antiepileptic drug, which has been approved by FDA for the treatment of local seizures in epileptic patients aged 16 and over. It can be used in laboratory research and pharmaceutical research and development process.

CAS No.

357336-20-0

Formula

C11H20N2O2

Molecular Mass

212.29

Exact Mass

212.15200

PSA

63.40000

Logp

1.53710

IUPAC

(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide

SMILES

CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N

Matter Classification

organic

GET SAMPLE